Characterizing Real-world Functional Outcomes in Patients With Geographic Atrophy: An IRIS Registry Analysis

Access Resources

Impact of the Complement C3 Inhibitor Pegcetacoplan on Photoreceptor Degeneration beyond Areas of Geographic Atrophy in the FILLY Trial

Access Resources

Geographic Atrophy Lesion Growth in Pegcetacoplan-treated Study Eyes Versus Untreated Fellow Eyes in Patients with Bilateral GA in the OAKS, DERBY, and FILLY Trials

Access Resources

Efficacy of Pegcetacoplan in Subgroups Defined by Distance from the Foveal Center Point in the Phase 3 OAKS and DERBY studies of Patients with Geographic Atrophy

Access Resources